J R C is counted at the forefront in the league of reliable Suppliers of Pharma Intermediates. We are also recognized as one of the most successful Pharmaceutical Intermediates Manufacturers. We offer different kinds of Active Pharmaceutical Intermediates, the list of which is provided below:
| INTERMEDIATE NAME | CAS NO | END PRODUCT |
|---|---|---|
| 5, Amino 2,4,6 triidoisophthalic acid | (35453-19-1) | IOPAMIDOL & IOHEXOL |
| 5,Amino 2,4,6 Triiodoisophtholyl dichloride | (37441-29-5) | IOPAMIDOL & IOHEXOL |
| 5 Amino-N,N bis-2,3 dihydroxy propyl-isophthalamide | (203515-86-0) | IOPAMIDOL & IOHEXOL |
| 2-(4-(Oxo-1-Cyclopropanyl)-phenyl-2-methyl propanoic acid | (162096-54-0) | FEXOFENADINE HCl |
| Methyl-4-(4-Chloro-1-oxobutyl) – α, α-dimethyl phenyl acetate | (154477-54-0) | FEXOFENADINE HCl |
| 1-(2,6-Dichlorophenyl)-2-Indolinone | (15362-40-0) | DICLOFENAC SODIUM |
| N-phenyl N chloro acetyl 2,6 dichloro aniline | (15304-01-7) | DICLOFENAC SODIUM |
| 4-Amino-6-chlorobenzene-1, 3-disulfonamide | (121-30-2) | HYDROCHLOROTHIAZIDE |
| Lasamide | (2736-23-4) | FUROSEMIDE |
| S(-) Octabase | (30356-07-1) | DEXTROMETHORPHAN HBr |
| N-Formyl Octabase | (51773-23-0) | DEXTROMETHORPHAN HBr |
| N-Formyl 3 methoxy Morphinan | (28793-48-0) | DEXTROMETHORPHAN HBr |
| 3-Methoxy Morphinan | (1531-25-5) | DEXTROMETHORPHAN HBr |
| Dextromethorphan Base | (125-71-3) | DEXTROMETHORPHAN HBr |
| 1-[Amino (p Methoxyphenyl) Ethyl] Cyclhexanol HCL : VNF Stage-II | (130198-05-9) | VENLAFAXINE |
| Venlafaxine Base | Venlafaxine Base | VENLAFAXINE |
| S(-)Octabase Mandelate | (97232-75-2) | DEXTROMETHORPHAN HBr |
| (+)-3-Methoxy-17-methylmorphinan | (125-71-3) | DEXTROMETHORPHAN HBr |
| 1,2 Dimethyl-1,4,5,6 Tetrahydropyrimidine | (4271-96-9) | PYRANTEL PAMOATE |
| Thiophene-2-aldehyde | (98-03-3) | PYRANTEL PAMOATE |
| Disodium pamoate | (6640-22-8) | PYRANTEL PAMOATE |
Disclaimer :
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. However, the final responsibility with respect to third party patent rights in a specific country, lies exclusively with the user.
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. However, the final responsibility with respect to third party patent rights in a specific country, lies exclusively with the user.